Coronary artery bypass surgery compared with medical therapy alone for ischaemic heart disease | |||||
Patient or population: Adult patients with ischaemic heart disease Settings: Hospital Intervention: Coronary artery bypass surgery Comparison: Medical therapy | |||||
Outcomes | Illustrative comparative risks a (95% CI) | Relative effect (95% CI) | No of Participants (studies) | Quality of the evidence (GRADE) | |
Assumed risk | Corresponding risk | ||||
Medical therapy | Coronary artery bypass surgery | ||||
All-cause mortality [follow-up] | Low risk population | RR [value] ([value] to [value]) | [value] ([value]) | ⊕⊝⊝⊝ very low ⊕⊕⊝⊝ low ⊕⊕⊕⊝ moderate ⊕⊕⊕⊕ high | |
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Medium risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
High risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Serious adverse events [follow-up] | Low risk population | RR [value] ([value] to [value]) | [value] ([value]) | ⊕⊝⊝⊝ very low ⊕⊕⊝⊝ low ⊕⊕⊕⊝ moderate ⊕⊕⊕⊕ high | |
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Medium risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
High risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Quality of life [follow-up] | The mean quality of life rating ranged across control groups from [value][measure] | The mean quality of life rating in the intervention groups was [value] [lower/higher] [(value to value lower/higher)] | [value] ([value]) | ||
Cardiovascular mortality [follow-up] | Low risk population | RR [value] ([value] to [value]) | [value] ([value]) | ⊕⊝⊝⊝ very low ⊕⊕⊝⊝ low ⊕⊕⊕⊝ moderate ⊕⊕⊕⊕ high | |
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Medium risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
High risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Myocardial infarction [follow-up] | Low risk population | RR [value] ([value] to [value]) | [value] ([value]) | ⊕⊝⊝⊝ very low ⊕⊕⊝⊝ low ⊕⊕⊕⊝ moderate ⊕⊕⊕⊕ high | |
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Medium risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
High risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Angina [follow-up] | The mean angina rating ranged across control groups from [value][measure] | The mean angina rating in the intervention groups was [value] [lower/higher] [(value to value lower/higher)] | [value] ([value]) | ⊕⊝⊝⊝ very low ⊕⊕⊝⊝ low ⊕⊕⊕⊝ moderate ⊕⊕⊕⊕ high | |
Stroke [follow-up] | Low risk population | RR [value] ([value] to [value]) | [value] ([value]) | ⊕⊝⊝⊝ very low ⊕⊕⊝⊝ low ⊕⊕⊕⊝ moderate ⊕⊕⊕⊕ high | |
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Medium risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
High risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Non-serious adverse events [follow-up] | Low risk population | RR [value] ([value] to [value]) | [value] ([value]) | ⊕⊝⊝⊝ very low ⊕⊕⊝⊝ low ⊕⊕⊕⊝ moderate ⊕⊕⊕⊕ high | |
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
Medium risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) | ||||
High risk population | |||||
[value] per 1000 | [value] per 1000 ([value] to [value]) |